ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 186 filers reported holding ADMA BIOLOGICS INC in Q4 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $10,088,767 | +4.5% | 1,528,601 | -28.4% | 4.58% | -18.7% |
Q4 2023 | $9,655,172 | +55.3% | 2,136,100 | +23.0% | 5.64% | +12.4% |
Q3 2023 | $6,215,238 | -38.2% | 1,736,100 | -36.3% | 5.01% | -46.3% |
Q2 2023 | $10,059,128 | -24.0% | 2,726,051 | -31.8% | 9.34% | -17.2% |
Q1 2023 | $13,240,000 | -14.7% | 4,000,000 | 0.0% | 11.29% | -17.7% |
Q4 2022 | $15,520,000 | +21.2% | 4,000,000 | -24.1% | 13.71% | +8.0% |
Q3 2022 | $12,804,000 | +6.5% | 5,269,155 | -13.2% | 12.70% | +4.1% |
Q2 2022 | $12,026,000 | +12.9% | 6,073,598 | +4.3% | 12.20% | +23.4% |
Q1 2022 | $10,656,000 | +40.0% | 5,822,798 | +7.9% | 9.89% | +67.4% |
Q4 2021 | $7,611,000 | – | 5,397,798 | – | 5.91% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 883,214 | $1,722,000 | 0.80% |
Telemetry Investments, L.L.C. | 200,615 | $391,000 | 0.66% |
Perceptive Advisors | 16,584,802 | $32,340,000 | 0.35% |
Consonance Capital Management LP | 1,558,290 | $3,039,000 | 0.28% |
683 Capital Management, LLC | 2,000,000 | $3,900,000 | 0.18% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 627,931 | $1,224,000 | 0.15% |
GSA CAPITAL PARTNERS LLP | 327,052 | $638,000 | 0.10% |
APOGEM CAPITAL LLC | 54,240 | $106,000 | 0.07% |
HUSSMAN STRATEGIC ADVISORS, INC. | 82,000 | $160,000 | 0.04% |
J. Goldman & Co LP | 376,319 | $734,000 | 0.04% |